<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37005767</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2768-6698</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>20</Day></PubDate></JournalIssue><Title>Frontiers in bioscience (Landmark edition)</Title><ISOAbbreviation>Front Biosci (Landmark Ed)</ISOAbbreviation></Journal><ArticleTitle>The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review.</ArticleTitle><Pagination><StartPage>59</StartPage><MedlinePgn>59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.31083/j.fbl2803059</ELocationID><Abstract><AbstractText>Immunothrombosis has emerged as a dominant pathological process exacerbating morbidity and mortality in acute- and long-COVID-19 infections. The hypercoagulable state is due in part to immune system dysregulation, inflammation and endothelial cell damage, as well as a reduction in defense systems. One defense mechanism in particular is glutathione (GSH), a ubiquitously found antioxidant. Evidence suggests that reduction in GSH increases viral replication, pro-inflammatory cytokine release, and thrombosis, as well as decreases macrophage-mediated fibrin removal. The collection of adverse effects as a result of GSH depletion in states like COVID-19 suggest that GSH depletion is a dominant mechanism of immunothrombosis cascade. We aim to review the current literature on the influence of GSH on COVID-19 immunothrombosis pathogenesis, as well as the beneficial effects of GSH as a novel therapeutic for acute- and long-COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s). Published by IMR Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glassman</LastName><ForeName>Ira</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Nghia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirhosseini</LastName><ForeName>Mercedeh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcantara</LastName><ForeName>Cheldon Ann</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asif</LastName><ForeName>Aamna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goulding</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muneer</LastName><ForeName>Shafi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Manpreet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Corona Regional Medical Center, Corona, CA 92882, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robison</LastName><ForeName>Jeremiah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, St. Barnabas Hospital Health System, Bronx, NY 10457, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guilford</LastName><ForeName>Frederick</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Your Energy System, Palo Alto, CA 94301, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venketaraman</LastName><ForeName>Vishwanath</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R15 HL143545</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Front Biosci (Landmark Ed)</MedlineTA><NlmUniqueID>101612996</NlmUniqueID><ISSNLinking>2768-6698</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber><NameOfSubstance UI="D005978">Glutathione</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090882" MajorTopicYN="N">Thromboinflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">GSH</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">glutathione</Keyword><Keyword MajorTopicYN="N">immunothrombosis</Keyword><Keyword MajorTopicYN="N">microclot</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. VV is serving as one of the Guest editors of this journal. We declare that VV had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to ESH.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37005767</ArticleId><ArticleId IdType="mid">NIHMS1919706</ArticleId><ArticleId IdType="pmc">PMC10406467</ArticleId><ArticleId IdType="doi">10.31083/j.fbl2803059</ArticleId><ArticleId IdType="pii">S2768-6701(23)00838-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nature Reviews. Immunology 2021; 21: 319&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, et al. COVID-19 Mechanisms in the Human Body-What We Know So Far. Frontiers in Immunology. 2021; 12: 693938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592035</ArticleId><ArticleId IdType="pubmed">34790191</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clinical Immunology. 2020; 215: 108427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169933</ArticleId><ArticleId IdType="pubmed">32325252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekim M, Sekeroglu MR, Balahoroglu R, Ozkol H, Ekim H. Roles of the Oxidative Stress and ADMA in the Development of Deep Venous Thrombosis. Biochemistry Research International. 2014; 2014: 703128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003758</ArticleId><ArticleId IdType="pubmed">24818025</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw RJ, Bradbury C, Abrams ST, Wang G, Toh CH. COVID-19 and immunothrombosis: emerging understanding and clinical management. British Journal of Haematology. 2021; 194: 518&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">34114204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. The Biochemical Journal. 2022; 479: 537&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacchiarini L, Tua A, Grignani G. In vitro effect of reduced glutathione on platelet function. Haematologica. 1996; 81: 497&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">9009436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lage SL, Amaral EP, Hilligan KL, Laidlaw E, Rupert A, Namasivayan S, et al. Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16&#x2212; Monocytes From COVID-19 Patients. Frontiers in Immunology. 2022; 12: 799558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8795739</ArticleId><ArticleId IdType="pubmed">35095880</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvagno F, Vernone A, Pescarmona GP. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19. Antioxidants. 2020; 9: 624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402141</ArticleId><ArticleId IdType="pubmed">32708578</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri JW, Angelin A, Murdock DG, Schaefer P, Portluri P, Lie T, et al. SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore. BioRxiv. 2023; 14: 1064293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9986324</ArticleId><ArticleId IdType="pubmed">36891303</ArticleId></ArticleIdList></Reference><Reference><Citation>Guloyan V, Oganesian B, Baghdasaryan N, Yeh C, Singh M, Guilford F, et al. Glutathione Supplementation as an Adjunctive Therapy in COVID-19. Antioxidants. 2020; 9: 914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7601802</ArticleId><ArticleId IdType="pubmed">32992775</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdivia A, Ly J, Gonzalez L, Hussain P, Saing T, Islamoglu H, et al. Restoring Cytokine Balance in HIV-Positive Individuals with Low CD4 T Cell Counts. AIDS Research and Human Retroviruses. 2017; 33: 905&#x2013;918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576219</ArticleId><ArticleId IdType="pubmed">28398068</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman N, Taubman M. Tissue factor: past, present, and future. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009; 29: 1986&#x2013;1988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848486</ArticleId><ArticleId IdType="pubmed">19923557</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nature Reviews. Immunology 2013; 13: 34&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">23222502</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, O&#x2019;Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. The Lancet. Rheumatology 2020; 2: e437&#x2013;e445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252093</ArticleId><ArticleId IdType="pubmed">32835247</ArticleId></ArticleIdList></Reference><Reference><Citation>Loscalzo J. Oxidative stress in endothelial cell dysfunction and thrombosis. Pathophysiology of Haemostasis and Thrombosis. 2002; 32: 359&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">13679676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H, et al. Cell Type-Specific Roles of NF-&#x3ba;B Linking Inflammation and Thrombosis. Frontiers in Immunology. 2019; 10: 85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6369217</ArticleId><ArticleId IdType="pubmed">30778349</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Andrews NP, Padder FA, Husain M, Quyyumi AA. Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability. Journal of the American College of Cardiology. 1999; 34: 507&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">10440166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. The New England Journal of Medicine. 2020; 383: 120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro) Thrombosis in COVID-19 and Its Therapeutic Implications. Circulation Research. 2020; 127: 571&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386875</ArticleId><ArticleId IdType="pubmed">32586214</ArticleId></ArticleIdList></Reference><Reference><Citation>Overton PM, Toshner M, Mulligan C, Vora P, Nikkho S, de Backer J, et al. Pulmonary thromboembolic events in COVID-19-A systematic literature review. Pulmonary Circulation. 2022; 12: e12113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349961</ArticleId><ArticleId IdType="pubmed">35942076</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine. 2009; 30: 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2696075</ArticleId><ArticleId IdType="pubmed">18796312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov AV, Maksimova MY, Nikiforova KA, Ochtova FR, Suanova ET, Alexandrin VVE, et al. Plasma glutathione as a risk marker for the severity and functional outcome of acute atherothrombotic and cardioembolic stroke. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2022; 58: 15.</Citation></Reference><Reference><Citation>Gibson KR, Winterburn TJ, Barrett F, Sharma S, MacRury SM, Megson IL. Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes. Cardiovascular Diabetology. 2011; 10: 43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120650</ArticleId><ArticleId IdType="pubmed">21600014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin RC, Mahoney CE, Coleman Anderson L, Ottaviano F, Croce K, Leopold JA, et al. Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo. Circulation. 2011; 123: 1963&#x2013;1973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3107543</ArticleId><ArticleId IdType="pubmed">21518981</ArticleId></ArticleIdList></Reference><Reference><Citation>Voetsch B, Jin RC, Bierl C, Benke KS, Kenet G, Simioni P, et al. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke. 2007; 38: 41&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1781064</ArticleId><ArticleId IdType="pubmed">17122425</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayal S, Wilson KM, Motto DG, Miller FJ Jr, Chauhan AK, Lentz SR. Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation. 2013; 127: 1308&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4447136</ArticleId><ArticleId IdType="pubmed">23426106</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas G, Skrinska V, Lucas FV, Schumacher OP. Platelet glutathione and thromboxane synthesis in diabetes. Diabetes. 1985; 34: 951&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pubmed">3930319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitka O, Skalickova S, Gumulec J, Masarik M, Adam V, Hubalek J, et al. Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncology Letters. 2012; 4: 1247&#x2013;1253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3506742</ArticleId><ArticleId IdType="pubmed">23205122</ArticleId></ArticleIdList></Reference><Reference><Citation>Essex DW, Li M, Feinman RD, Miller A. Platelet surface glutathione reductase-like activity. Blood. 2004; 104: 1383&#x2013;1385.</Citation><ArticleIdList><ArticleId IdType="pubmed">15142878</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang X, Lv X, Jin Q, Shang H, Wang CC, et al. The extracellular Ero1&#x3b1;/PDI electron transport system regulates platelet function by increasing glutathione reduction potential. Redox Biology. 2022; 50: 102244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792282</ArticleId><ArticleId IdType="pubmed">35077997</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas G, Skrinska VA, Lucas FV. The influence of glutathione and other thiols on human platelet aggregation. Thrombosis Research. 1986; 44: 859&#x2013;866.</Citation><ArticleIdList><ArticleId IdType="pubmed">3099423</ArticleId></ArticleIdList></Reference><Reference><Citation>Masselli E, Pozzi G, Vaccarezza M, Mirandola P, Galli D, Vitale M, et al. ROS in Platelet Biology: Functional Aspects and Methodological Insights. International Journal of Molecular Sciences. 2020; 21: 4866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402354</ArticleId><ArticleId IdType="pubmed">32660144</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez de Lizarrondo S, Gakuba C, Herbig BA, Repess&#xe9; Y, Ali C, Denis CV, et al. Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi. Circulation. 2017; 136: 646&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5560034</ArticleId><ArticleId IdType="pubmed">28487393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Yee Aw T, Stokes KY. N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes. Redox Biology. 2018; 14: 218&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619994</ArticleId><ArticleId IdType="pubmed">28961512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yegiazaryan A, Abnousian A, Alexander LJ, Badaoui A, Flaig B, Sheren N, et al. Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19. International Journal of Molecular Sciences. 2022; 23: 9297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9409103</ArticleId><ArticleId IdType="pubmed">36012562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Osahon O, Vides DB, Hanania N, Minard CG, Sekhar RV. Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation. Antioxidants. 2021; 11: 50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8773164</ArticleId><ArticleId IdType="pubmed">35052554</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. Journal of Intensive Care. 2020; 8: 49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7348129</ArticleId><ArticleId IdType="pubmed">32665858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly J, Lagman M, Saing T, Singh MK, Tudela EV, Morris D, et al. Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals. Journal of Interferon &amp; Cytokine Research. 2015; 35: 875&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4642835</ArticleId><ArticleId IdType="pubmed">26133750</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagman M, Ly J, Saing T, Kaur Singh M, Vera Tudela E, Morris D, et al. Investigating the causes for decreased levels of glutathione in individuals with type II diabetes. PLoS ONE. 2015; 10: e0118436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366217</ArticleId><ArticleId IdType="pubmed">25790445</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles LA, Parmer RJ. Angry macrophages patrol for fibrin. Blood. 2016; 127: 1079&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4778160</ArticleId><ArticleId IdType="pubmed">26941388</ArticleId></ArticleIdList></Reference><Reference><Citation>Checconi P, De Angelis M, Marcocci ME, Fraternale A, Magnani M, Palamara AT, et al. Redox-Modulating Agents in the Treatment of Viral Infections. International Journal of Molecular Sciences. 2020; 21: 4084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312898</ArticleId><ArticleId IdType="pubmed">32521619</ArticleId></ArticleIdList></Reference><Reference><Citation>Talasaz AH, Sadeghipour P, Kakavand H, Aghakouchakzadeh M, Kordzadeh-Kermani E, Van Tassell BW, et al. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2021; 77: 1903&#x2013;1921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7963001</ArticleId><ArticleId IdType="pubmed">33741176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D, Sperhake JP, L&#xfc;tgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Annals of Internal Medicine. 2020; 173: 268&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, et al. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis. American Journal of Hematology. 2021; 96: 471&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013588</ArticleId><ArticleId IdType="pubmed">33476420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryukov EV, Ivanov AV, Karpov VO, Vasil&#x2019;evich Alexandrin V, Dygai AM, Kruglova MP, et al. Association of Low Molecular Weight Plasma Aminothiols with the Severity of Coronavirus Disease 2019. Oxidative Medicine and Cellular Longevity. 2021; 2021: 9221693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455204</ArticleId><ArticleId IdType="pubmed">34557267</ArticleId></ArticleIdList></Reference><Reference><Citation>Agita A, Alsagaff MT. Inflammation, Immunity, and Hypertension. Acta Medica Indonesiana. 2017; 49: 158&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">28790231</ArticleId></ArticleIdList></Reference><Reference><Citation>Polonikov A. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. ACS Infectious Diseases. 2020; 6: 1558&#x2013;1562.</Citation><ArticleIdList><ArticleId IdType="pubmed">32463221</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanfar A, Al Qaroot B. Could glutathione depletion be the Trojan horse of COVID-19 mortality? European Review for Medical and Pharmacological Sciences. 2020; 24: 12500&#x2013;12509.</Citation><ArticleIdList><ArticleId IdType="pubmed">33336769</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nature Reviews. Molecular Cell Biology 2022; 23: 3&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181: 271&#x2013;280.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of Infection and Public Health. 2020; 13: 1833&#x2013;1839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402107</ArticleId><ArticleId IdType="pubmed">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. Journal of Hematology &amp; Oncology. 2020; 13: 120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu JK, Sozmen EG, Dixit K, Montano M, Matsui Y, Liu Y, et al. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. bioRxiv. 2021. (preprint)</Citation></Reference><Reference><Citation>Liao QJ, Ye LB, Timani KA, Zeng YC, She YL, Ye L, et al. Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus. Acta Biochimica et Biophysica Sinica. 2005; 37: 607&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7109668</ArticleId><ArticleId IdType="pubmed">16143815</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wu K, Wang D, Yue X, Song D, Zhu Y, et al. Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB. Virology. 2007; 365: 324&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103332</ArticleId><ArticleId IdType="pubmed">17490702</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yu C, Jing H, Wu X, Novakovic VA, Xie R, et al. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation. Frontiers in Cellular and Infection Microbiology. 2022; 12: 861703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentsch CT, Beckman JA, Tomlinson L, Gellad WF, Alcorn C, Kidwai-Khan F, et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. British Medical Journal. 2021; 372: n311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876672</ArticleId><ArticleId IdType="pubmed">33574135</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan Y, Yilmaz G, Dogan D, Hasirci M, Cetindogan H, Ocal N, et al. The effectiveness of early anticoagulant treatment in Covid-19 patients. Phlebology. 2021; 36: 384&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">33243082</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. American Journal of Hematology. 2020; 95: 834&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Ochoa AJ, Raffetto JD, Hern&#xe1;ndez AG, Zavala N, Guti&#xe9;rrez O, Vargas A, et al. Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial. Thrombosis and Haemostasis. 2021; 121: 944&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pubmed">33677827</ArticleId></ArticleIdList></Reference><Reference><Citation>Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. The New England Journal of Medicine. 2021; 385: 777&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362592</ArticleId><ArticleId IdType="pubmed">34351722</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro F, Nu&#xf1;ez-Gil IJ, Vitale E, Viana-Llamas MC, Reche-Martinez B, Romero-Pareja R, et al. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry. Heart. 2022; 108: 130&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494537</ArticleId><ArticleId IdType="pubmed">34611045</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2022; 399: 143&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8598213</ArticleId><ArticleId IdType="pubmed">34800427</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz RI, Freeman PR, Bruzzese J. Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases. Respiratory Medicine Case Reports. 2020; 30: 101063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172740</ArticleId><ArticleId IdType="pubmed">32322478</ArticleId></ArticleIdList></Reference><Reference><Citation>Justiz Vaillant AA, Qurie A. Interleukin. In StatPearls. 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK499840/ (Accessed: 5 January 2023).</Citation></Reference><Reference><Citation>Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-&#x3b3;: receptors, functions, and roles in diseases. The Journal of Allergy and Clinical Immunology. 2011; 127: 701&#x2013;721.e270.</Citation><ArticleIdList><ArticleId IdType="pubmed">21377040</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda K, Mehta H, Drevets DA, Coggeshall KM. IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production. Blood. 2010; 115: 4699&#x2013;1706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3790945</ArticleId><ArticleId IdType="pubmed">20351305</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuzzocrea S, De Sarro G, Costantino G, Ciliberto G, Mazzon E, De Sarro A, et al. IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock. Journal of Leukocyte Biology. 1999; 66: 471&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">10496318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus Disease 2019-COVID-19. Clinical Microbiology Reviews. 2020; 33: e00028&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405836</ArticleId><ArticleId IdType="pubmed">32580969</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. The New England Journal of Medicine. 2020; 382: 2372&#x2013;2374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajner SM, Goemann IM, Bueno AL, Larsen PR, Maia AL. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. The Journal of Clinical Investigation. 2011; 121: 1834&#x2013;1845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3083773</ArticleId><ArticleId IdType="pubmed">21540553</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta A, Das S, Sarkar PK. Thyroid hormone promotes glutathione synthesis in astrocytes by up regulation of glutamate cysteine ligase through differential stimulation of its catalytic and modulator subunit mRNAs. Free Radical Biology &amp; Medicine. 2007; 42: 617&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">17291985</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhang Z, Wei R, Miao X, Sun S, Liang G, et al. IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p. Arteriosclerosis, Thrombosis, and Vascular Biology. 2020; 40: 323&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6975520</ArticleId><ArticleId IdType="pubmed">31852218</ArticleId></ArticleIdList></Reference><Reference><Citation>Senchenkova EY, Komoto S, Russell J, Almeida-Paula LD, Yan LS, Zhang S, et al. Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis. The American Journal of Pathology. 2013; 183: 173&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3702741</ArticleId><ArticleId IdType="pubmed">23673000</ArticleId></ArticleIdList></Reference><Reference><Citation>Massagu&#xe9; J. TGFbeta in Cancer. Cell. 2008; 134: 215&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3512574</ArticleId><ArticleId IdType="pubmed">18662538</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity. 2008; 28: 468&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">18400189</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MO, Flavell RA. TGF-beta: a master of all T cell trades. Cell. 2008; 134: 392&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677783</ArticleId><ArticleId IdType="pubmed">18692464</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu RM, Vayalil PK, Ballinger C, Dickinson DA, Huang WT, Wang S, et al. Transforming growth factor &#x3b2; suppresses glutamate-cysteine ligase gene expression and induces oxidative stress in a lung fibrosis model. Free Radical Biology &amp; Medicine. 2012; 53: 554&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3432394</ArticleId><ArticleId IdType="pubmed">22634145</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu RM, Gaston Pravia KA. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radical Biology &amp; Medicine. 2010; 48: 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2818240</ArticleId><ArticleId IdType="pubmed">19800967</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsalane K, Dubois CM, Muanza T, B&#xe9;gin R, Boudreau F, Asselin C, et al. Transforming growth factor-beta1 is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase. American Journal of Respiratory Cell and Molecular Biology. 1997; 17: 599&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">9374111</ArticleId></ArticleIdList></Reference><Reference><Citation>Linkins LA, Takach Lapner S. Review of D-dimer testing: Good, Bad, and Ugly. International Journal of Laboratory Hematology. 2017; 39: 98&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">28447414</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitz JI, Fredenburgh JC, Eikelboom JW. A Test in Context: D-Dimer. Journal of the American College of Cardiology. 2017; 70: 2411&#x2013;2420.</Citation><ArticleIdList><ArticleId IdType="pubmed">29096812</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009; 113: 2878&#x2013;2887.</Citation><ArticleIdList><ArticleId IdType="pubmed">19008457</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer K, Goldschmidt E, Oostra D, Fish J, Russell T, Lurie F. The clinical significance of ultra-high D-dimer levels. Journal of Vascular Surgery. Venous and Lymphatic Disorders 2022; 10: 8&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220196</ArticleId><ArticleId IdType="pubmed">34171532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zennadi R. Oxidative Stress and Thrombosis during Aging: The Roles of Oxidative Stress in RBCs in Venous Thrombosis. International Journal of Molecular Sciences. 2020; 21: 4259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7352981</ArticleId><ArticleId IdType="pubmed">32549393</ArticleId></ArticleIdList></Reference><Reference><Citation>Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden. Arteriosclerosis, Thrombosis, and Vascular Biology 2014; 34: 2363&#x2013;2371.</Citation><ArticleIdList><ArticleId IdType="pubmed">25304324</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwose EU, Jelinek HF, Richards RS, Tinley P, Kerr PG. Atherothrombosis and oxidative stress: the connection and correlation in diabetes. Redox Report. 2009; 14: 55&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19389272</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, et al. Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Cardiology in Review. 2020; 28: 295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437424</ArticleId><ArticleId IdType="pubmed">33017364</ArticleId></ArticleIdList></Reference><Reference><Citation>Loscalzo J. The macrophage and fibrinolysis. Seminars in Thrombosis and Hemostasis. 1996; 22: 503&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">9122715</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;ckerl D. Macrophages and parasites: Mortal enemies or partners in crime? Parasite Immunology. 2020; 42: e12725.</Citation><ArticleIdList><ArticleId IdType="pubmed">32350886</ArticleId></ArticleIdList></Reference><Reference><Citation>Motley MP, Madsen DH, J&#xfc;rgensen HJ, Spencer DE, Szabo R, Holmbeck K, et al. A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo. Blood. 2016; 127: 1085&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4778161</ArticleId><ArticleId IdType="pubmed">26647393</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonda SR, Shainoff JR. Adsorptive endocytosis of fibrin monomer by macrophages: evidence of a receptor for the amino terminus of the fibrin alpha chain. Proceedings of the National Academy of Sciences of the United States of America. 1982; 79: 4565&#x2013;4569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC346715</ArticleId><ArticleId IdType="pubmed">6289305</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth K, Strickland J, Copple BL. Regulation of macrophage activation in the liver after acute injury: Role of the fibrinolytic system. World Journal of Gastroenterology. 2020; 26: 1879&#x2013;1887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201151</ArticleId><ArticleId IdType="pubmed">32390699</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva LM, Lum AG, Tran C, Shaw MW, Gao Z, Flick MJ, et al. Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation. Blood. 2019; 134: 291&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6639982</ArticleId><ArticleId IdType="pubmed">31101623</ArticleId></ArticleIdList></Reference><Reference><Citation>Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood. 2016; 128: 753&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pubmed">27354721</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M, Vaughn C, Sasaninia K, Yeh C, Mehta D, Khieran I, et al. Understanding the Relationship between Glutathione, TGF-&#x3b2;, and Vitamin D in Combating Mycobacterium tuberculosis Infections. Journal of Clinical Medicine. 2020; 9: 2757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7563738</ArticleId><ArticleId IdType="pubmed">32858837</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris D, Guerra C, Khurasany M, Guilford F, Saviola B, Huang Y, et al. Glutathione supplementation improves macrophage functions in HIV. Journal of Interferon &amp; Cytokine Research. 2013; 33: 270&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">23409922</ArticleId></ArticleIdList></Reference><Reference><Citation>To K, Cao R, Yegiazaryan A, Owens J, Nguyen T, Sasaninia K, et al. Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes. Frontiers in Cellular and Infection Microbiology. 2021; 11: 657775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8211104</ArticleId><ArticleId IdType="pubmed">34150674</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolini D, Stabile AM, Bastianelli S, Giustarini D, Pierucci S, Busti C, et al. SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione. Redox Biology. 2021; 45: 102041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8190457</ArticleId><ArticleId IdType="pubmed">34146958</ArticleId></ArticleIdList></Reference><Reference><Citation>Labarrere CA, Kassab GS. Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease. Frontiers in Microbiology. 2022; 13: 979719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9582773</ArticleId><ArticleId IdType="pubmed">36274722</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radical Biology &amp; Medicine. 2009; 46: 443&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634824</ArticleId><ArticleId IdType="pubmed">19028565</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty MF, DiNicolantonio JJ. An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderly. Age. 2015; 37: 96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5005830</ArticleId><ArticleId IdType="pubmed">26362762</ArticleId></ArticleIdList></Reference><Reference><Citation>Murae M, Shimizu Y, Yamamoto Y, Kobayashi A, Houri M, Inoue T, et al. The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione. Biochemical and Biophysical Research Communications. 2022; 597: 30&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8800159</ArticleId><ArticleId IdType="pubmed">35123263</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>